Search

Search

Esta página ha sido traducida por una máquina. Otras páginas pueden seguir apareciendo en inglés. View in English

Home
...
Áreas de investigación Ciencias de la salud Salud pública Promoción de la salud
Áreas de investigación
Ciencias de la salud
Salud pública
Promoción de la salud
La efectividad de los mandatos de vacunación en la mejora de la absorción de las vacunas contra la COVID-19 en los Estados Unidos

La efectividad de los mandatos de vacunación en la mejora de la absorción de las vacunas contra la COVID-19 en los Estados Unidos

Michelle M Mello ¹, Douglas J Opel ², Regina M Benjamin ³, Timothy Callaghan ⁴, Renee DiResta ⁵, Jad A Elharake ⁶, Lisa C Flowers ⁷, Alison P Galvani ⁸, Daniel A Salmon ⁹, Jason L Schwartz ¹⁰, Noel T Brewer ¹¹, Alison M Buttenheim ¹², Richard M Carpiano ¹³, Chelsea Clinton ¹⁴, Peter J Hotez ¹⁵, Rekha Lakshmanan ¹⁶, Yvonne A Maldonado ¹⁷, Saad B Omer ¹⁸, Joshua M Sharfstein ¹⁹, Arthur Caplan ²⁰

Michelle M Mello ¹, Douglas J Opel ², Regina M Benjamin ³

¹Stanford Law School, Stanford University, Stanford, CA, USA; Department of Health Policy, Stanford University, Stanford, CA, USA; School of Medicine, Freeman Spogli Institute for International Studies, Stanford University, Stanford, CA, USA.
²Department of Pediatrics, University of Washington School of Medicine, Seattle, WA, USA; Treuman Katz Center for Pediatric Bioethics, Seattle Children's Research Institute, Seattle, WA, USA.
³Gulf States Health Policy Center, Bayou La Batre, AL, USA.
⁴Department of Health Policy and Management, School of Public Health, Texas A&M University, College Station, TX, USA.
⁵Stanford Internet Observatory, Stanford University, Stanford, CA, USA.
⁶Yale Institute for Global Health and Department of Internal Medicine (Infectious Diseases), Yale School of Medicine, Yale School of Public Health, New Haven, CT, USA.
⁷Department of Obstetrics & Gynecology, Emory University, Atlanta, GA, USA.
⁸Center for Infectious Disease Modeling and Analysis, Yale School of Public Health, New Haven, CT, USA.
⁹Institute for Vaccine Safety, Department of International Health, Johns Hopkins University Bloomberg School of Public Health, Baltimore, MD, USA.
¹⁰Department of Health Policy and Management, Yale School of Public Health, New Haven, CT, USA.
¹¹Department of Health Behavior, Gillings School of Global Public Health and Lineberger Comprehensive Cancer Center, University of North Carolina, Chapel Hill, NC, USA.
¹²Department of Family and Community Health, School of Nursing, and Center for Health Incentives and Behavioral Economics, University of Pennsylvania, Philadelphia, PA, USA.
¹³School of Public Policy, University of California, Riverside, CA, USA.
¹⁴Clinton Foundation, New York, NY, USA; Clinton Health Access Initiative, Boston, MA, USA; Mailman School of Public Health, Columbia University, New York, NY, USA.
¹⁵Texas Children's Center for Vaccine Development, Departments of Pediatrics and Molecular Virology & Microbiology, National School of Tropical Medicine, Baylor College of Medicine, Houston, TX, USA; James A Baker III Institute for Public Policy, Rice University, Houston, TX, USA; Department of Biology, Baylor University, Waco, TX, USA; Hagler Institute for Advanced Study and Scowcroft Institute of International Affairs, Bush School of Government and Public Service, Texas A&M University, College Station, TX, USA.
¹⁶James A Baker III Institute for Public Policy, Rice University, Houston, TX, USA; The Immunization Partnership, Houston, TX, USA.
¹⁷Department of Epidemiology and Population Health, Stanford University, Stanford, CA, USA; Department of Pediatrics, Stanford University, Stanford, CA, USA.
¹⁸Yale Institute for Global Health and Department of Internal Medicine (Infectious Diseases), Yale School of Medicine, Yale School of Public Health, New Haven, CT, USA; Department of Epidemiology of Microbial Diseases, Yale School of Public Health, New Haven, CT, USA; Yale School of Nursing, Orange, CT, USA.
¹⁹Department of Health Policy and Management, Johns Hopkins University Bloomberg School of Public Health, Baltimore, MD, USA.
²⁰Langone School of Medicine, New York University, New York, NY, USA.

⁰Stanford Law School, Stanford University, Stanford, CA, USA; Department of Health Policy, Stanford University, Stanford, CA, USA; School of Medicine, Freeman Spogli Institute for International Studies, Stanford University, Stanford, CA, USA.

Lancet +

|

11 de julio de 2022

|

11 de julio de 2022

Videos de Experimentos Relacionados

Contact us if these videos are not relevant.

Evaluation of Host-Pathogen Responses and Vaccine Efficacy in Mice

Evaluation of Host-Pathogen Responses and Vaccine Efficacy in Mice

Published on: February 22, 2019

Fabrication of Pulsatile Polymeric Microparticles Encapsulating Rabies Antigen

Fabrication of Pulsatile Polymeric Microparticles Encapsulating Rabies Antigen

Published on: May 12, 2023

Efficient Transfection of <em>In vitro</em> Transcribed mRNA in Cultured Cells Using Peptide-Poloxamine Nanoparticles

Efficient Transfection of In vitro Transcribed mRNA in Cultured Cells Using Peptide-Poloxamine Nanoparticles

Published on: August 17, 2022

See all related videos

Resumen

No abstract available on PubMed

Videos de Experimentos Relacionados

Contact us Si estos videos no son relevantes.

Evaluation of Host-Pathogen Responses and Vaccine Efficacy in Mice

Evaluation of Host-Pathogen Responses and Vaccine Efficacy in Mice

Published on: February 22, 2019

Fabrication of Pulsatile Polymeric Microparticles Encapsulating Rabies Antigen

Fabrication of Pulsatile Polymeric Microparticles Encapsulating Rabies Antigen

Published on: May 12, 2023

Efficient Transfection of <em>In vitro</em> Transcribed mRNA in Cultured Cells Using Peptide-Poloxamine Nanoparticles

Efficient Transfection of In vitro Transcribed mRNA in Cultured Cells Using Peptide-Poloxamine Nanoparticles

Published on: August 17, 2022

See all related videos

Videos de Conceptos Relacionados

Vaccinations

Vaccinations

Overview

Vaccination is the administration of antigenic material from pathogens to confer immunity against a specific microorganism. Vaccination primes the immune system to recognize and mount an immune response faster and more effectively if the real pathogen is encountered. Vaccinations are one of the most efficient ways to protect both individual humans and the general public from disease. A growing anti-vaccination skepticism risks the successes of vaccination programs that helped reduce...

Cancer Vaccines

Cancer Vaccines

Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...

Dose-Response Relationship: Potency and Efficacy

Dose-Response Relationship: Potency and Efficacy

The potency of a drug is the measure of its ability to produce a biological response and can be compared by looking at the half-maximum effective concentration or EC50 values of different drugs. A lower EC50 value indicates higher potency of the drug. In the dose–response curve of two antihypertensive drugs, candesartan and irbesartan, a significant difference is observed in their EC50 values. A lower EC50 value for candesartan indicates that it is more potent than irbesartan, as it...

Healthcare Associated Infections II: Preventive Measures

Healthcare Associated Infections II: Preventive Measures

Essential infection prevention measures are based on the knowledge of the infection chain, the modes of transmission in healthcare settings, and the use of the best practices in all healthcare settings. Compulsory public reporting of healthcare-associated infection rates is needed to allow individuals and the community to make informed choices regarding selecting a healthcare facility.
The best practices for preventing healthcare-associated infections include hand hygiene, patient risk...

Active versus Passive Immunity

Active versus Passive Immunity

Immunity, along with the ability to limit pathogen growth to prevent significant body tissue damage, can be gained either by (1) actively developing an immune response within the individual after exposure to a pathogen or after getting vaccinated or (2) passively transferring immune components from an immune individual to one who is nonimmune. Both these forms of immunity can be found naturally and in medical practices.
Active Immunity
Active immunity refers to the resistance one develops...

Microorganisms in Medicine and Therapeutics

Microorganisms in Medicine and Therapeutics

Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.

Share

X
Facebook
LinkedIn
YouTube

ABOUT JoVE

Overview
Leadership
Blog
JoVE Help Center

AUTHORS

Publishing Process
Editorial Board
Scope & Policies
Peer Review
FAQ
Submit

LIBRARIANS

Testimonials
Subscriptions
Access
Resources
Library Advisory Board
FAQ

RESEARCH

JoVE Journal
Methods Collections
JoVE Encyclopedia of Experiments
Archive

EDUCATION

JoVE Core
JoVE Business
JoVE Science Education
JoVE Lab Manual
Faculty Resource Center
Faculty Site

Terms & Conditions of Use
Privacy Policy
Policies